Legend Biotech (NASDAQ:LEGN) is set to give its latest quarterly earnings report on Tuesday, 2026-03-10. Here’s what investors need to know before the announcement.
Analysts estimate that Legend Biotech will report an earnings per share (EPS) of $-0.18.
The announcement from Legend Biotech is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
In the previous earnings release, the company beat EPS by $0.07, leading to a 0.53% drop in the share price the following trading session.
Here’s a look at Legend Biotech’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.12 | -0.21 | -0.25 | -0.33 |
| EPS Actual | -0.05 | -0.34 | -0.07 | -0.15 |
| Price Change % | -0.53 | 2.07 | -10.55 | 2.82 |
Performance of Legend Biotech Shares
Shares of Legend Biotech were trading at $18.97 as of March 06. Over the last 52-week period, shares are down 47.88%. Given that these returns …